前置血管筛查、诊断、管理与结局:单中心研究
本研究回顾性分析了2010年1月至2024年10月在一家常规开展前置血管筛查的中心产前诊断的前置血管患者,共205例(189例单胎和16例双胎),其中25例(12.2%)消退,174例分娩时持续存在,全部经剖宫产分娩,中位分娩孕周35.1周,除一例单绒毛膜双羊膜囊双胎之一死亡外均活产,≥36周分娩的新生儿结局优于<36周分娩者,作者强烈支持实施前置血管筛查方案,但不推荐37周后分娩。
要点
- 常规筛查方案包括中孕期经腹超声识别脐带胎盘插入处及宫颈彩色多普勒扫查,对低置胎盘或前置胎盘者加做经阴道彩色多普勒超声。
- 产前诊断的前置血管患者中,25例(12.2%)消退,174例分娩时持续存在,全部剖宫产分娩,中位分娩孕周35.1周。
- 除一例单绒毛膜双羊膜囊双胎之一死亡外均活产,≥36周分娩的新生儿结局优于<36周分娩者。
核心结论
- 在常规开展前置血管筛查的中心,产前诊断的前置血管病例几乎全部获得围产期存活,作者强烈支持实施前置血管筛查方案,认为其可能显著降低与该病相关的高死胎率,但不推荐37周后分娩。
研究设计与样本
- 回顾性队列研究,纳入2010年1月至2024年10月在美国马萨诸塞州波士顿贝斯以色列女执事医疗中心产前诊断的前置血管患者205例(189例单胎和16例双胎),所有诊断均于中孕期筛查并在约32周经阴道超声确认。
主要发现
- 205例中25例(12.2%)前置血管消退,6例分娩记录不可用,剩余174例分娩时持续存在且均为产前诊断。
- 据作者所知,无假阳性或假阴性诊断。
- 所有患者均行剖宫产分娩,中位分娩孕周35.1周(四分位距34.6-35.9周)。
- 除一例单绒毛膜双羊膜囊双胎之一(因双胎输血综合征接受激光光凝治疗)死亡外,其余妊娠均活产。
- 与<36周分娩者相比,≥36周分娩者的新生儿结局改善。
关键数值与推荐
- 所有患者均在中孕期解剖扫查时经腹超声识别脐带胎盘插入处并在宫颈上方行彩色多普勒扫查进行筛查,对中孕期低置胎盘或前置胎盘者常规行经阴道超声彩色多普勒检查,所有诊断于约32周妊娠时确认。
- 作者不推荐37周后分娩。
临床怎么用
- 本研究中心常规对所有患者在中孕期解剖扫查时经腹超声识别脐带胎盘插入处并在宫颈上方行彩色多普勒扫查筛查前置血管,对中孕期低置胎盘或前置胎盘者常规行经阴道超声彩色多普勒检查,并在约32周妊娠时确认诊断。
- 作者强烈支持实施前置血管筛查方案,并认为其可能显著降低与该病相关的高死胎率。
- 作者不推荐37周后分娩。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the present study was to describe the diagnosis, management and outcomes of patients with prenatally diagnosed vasa previa (VP) at a single center in which routine VP screening is performed. METHODS: We carried out a retrospective cohort study of all patients with prenatally diagnosed VP at our institution (Beth Israel Deaconess Medical Center, Boston, MA, USA) between January 2010 and October 2024. We routinely screen all patients at the second-trimester anatomy scan by transabdominal ultrasound identification of the placental cord insertion and a color flow Doppler sweep over the cervix. We also routinely perform transvaginal ultrasound with color flow Doppler in all patients with a second-trimester low-lying placenta or placenta previa. We confirm all diagnoses in the third trimester, at approximately 32 weeks' gestation. Patients with VP were identified from the ultrasound and hospital databases. The primary outcome was perinatal survival in the screened patients, and we also compared neonatal outcomes between patients delivered < 36 or ≥ 36 weeks. RESULTS: There were 205 patients (189 singleton and 16 twin gestations) with prenatally diagnosed VP during the study period. Resolution occurred in 25 (12.2%) patients, and delivery records were unavailable for six, leaving 174 patients with unresolved VP at delivery, all of whom were diagnosed prenatally. To our knowledge, there were no false-positive or false-negative diagnoses. All patients underwent Cesarean delivery, at a median gestational age of 35.1 (interquartile range, 34.6-35.9) weeks. All except one of the pregnancies resulted in live birth. The single death occurred in one of a set of monochorionic diamniotic twins that underwent laser photocoagulation for twin-twin transfusion syndrome. Delivery ≥ 36 weeks resulted in improved neonatal outcomes when compared with patients delivering < 36 weeks. CONCLUSIONS: This study found almost universal perinatal survival in cases of prenatally diagnosed VP in a center with routine screening protocols for VP. These findings strongly support the implementation of a screening program for VP, which has the potential to significantly reduce the high rate of stillbirth associated with this condition. We do not, however, recommend delivery after 37 weeks' gestation. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Lueck T, Macharia A, Modest A, et al. Vasa previa screening, diagnosis, management and outcomes: single-center study. Ultrasound Obstet Gynecol. 2025. PMID: 40569011. doi:10.1002/uog.29268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。